The success of Sildenafil initially sparked a boom for major pharmaceutical companies, nevertheless recent shifts present a murky outlook for those considering a stake. Off-patent versions are reducing revenue, and https://diegozbox293779.qowap.com/100221180/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment